Literature DB >> 8663024

p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues.

W Miao1, L Eichelberger, L Baker, M S Marshall.   

Abstract

Previous structural studies of RasGAP have failed to clearly localize sites of Ras interaction to individual amino acids. Hypothesizing that sites of interaction with Ras-GTP would be conserved, 11 of the most highly conserved amino acid residues of RasGAP were changed by mutation. Each mutant protein was purified as a glutathione S-transferase catalytic domain fusion and analyzed for protein stability, Ras GTPase stimulating activity, affinity for Ras-GTP, and when possible, secondary structure. The majority of conserved positions were found to be important structurally but with no direct role in Ras interactions. However, Arg786, Lys831, and Arg925 were observed to be essential for binding to Ras-GTP but not for protein structure. RasGAP residues 890-902 (block 3A) were observed to be homologous to residues 1540-1552 of the yeast adenylyl cyclase with amino acid substitutions in both regions resulting in increased affinity for Ras. This is the first example of a conserved Ras interaction motif in distinct Ras effector proteins. Our data are supportive of a model for GAP/Ras-GTP association in which the conserved, positively charged Arg786, Lys831, and Arg925 residues form salt bridges with the conserved, negatively charged residues in the Ras effector loop.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8663024     DOI: 10.1074/jbc.271.26.15322

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and Interactions.

Authors:  Klaus Scheffzek; Giridhar Shivalingaiah
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

2.  RASA1 regulates the function of lymphatic vessel valves in mice.

Authors:  Philip E Lapinski; Beth A Lubeck; Di Chen; Abbas Doosti; Scott D Zawieja; Michael J Davis; Philip D King
Journal:  J Clin Invest       Date:  2017-05-22       Impact factor: 14.808

3.  Filaments and fingers: Novel structural aspects of the single septin from Chlamydomonas reinhardtii.

Authors:  Andressa P A Pinto; Humberto M Pereira; Ana E Zeraik; Heloisa Ciol; Frederico M Ferreira; José Brandão-Neto; Ricardo DeMarco; Marcos V A S Navarro; Cristina Risi; Vitold E Galkin; Richard C Garratt; Ana P U Araujo
Journal:  J Biol Chem       Date:  2017-05-05       Impact factor: 5.157

Review 4.  Signal transduction pathways and their relevance in human astrocytomas.

Authors:  M M Feldkamp; N Lau; A Guha
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

5.  p120RasGAP mediates ephrin/Eph-dependent attenuation of FGF/ERK signals during cell fate specification in ascidian embryos.

Authors:  Nicolas Haupaix; Alberto Stolfi; Cathy Sirour; Vincent Picco; Michael Levine; Lionel Christiaen; Hitoyoshi Yasuo
Journal:  Development       Date:  2013-09-25       Impact factor: 6.868

6.  A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy.

Authors:  M Abdellatif; S E Packer; L H Michael; D Zhang; M J Charng; M D Schneider
Journal:  Mol Cell Biol       Date:  1998-11       Impact factor: 4.272

7.  Blood vascular abnormalities in Rasa1(R780Q) knockin mice: implications for the pathogenesis of capillary malformation-arteriovenous malformation.

Authors:  Beth A Lubeck; Philip E Lapinski; Timothy J Bauler; Jennifer A Oliver; Elizabeth D Hughes; Thomas L Saunders; Philip D King
Journal:  Am J Pathol       Date:  2014-10-03       Impact factor: 4.307

8.  Decreased GTPase activity of K-ras mutants deriving from human functional adrenocortical tumours.

Authors:  S R Lin; C H Hsu; J H Tsai; J Y Wang; T J Hsieh; C H Wu
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

9.  Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.

Authors:  Hyeran Sung; Krishna L Kanchi; Xue Wang; Kristen S Hill; Jane L Messina; Ji-Hyun Lee; Youngchul Kim; Nathan D Dees; Li Ding; Jamie K Teer; Shengyu Yang; Amod A Sarnaik; Vernon K Sondak; James J Mulé; Richard K Wilson; Jeffrey S Weber; Minjung Kim
Journal:  Oncotarget       Date:  2016-04-26

10.  Recurrent inactivating RASA2 mutations in melanoma.

Authors:  Rand Arafeh; Nouar Qutob; Rafi Emmanuel; Alona Keren-Paz; Jason Madore; Abdel Elkahloun; James S Wilmott; Jared J Gartner; Antonella Di Pizio; Sabina Winograd-Katz; Sivasish Sindiri; Ron Rotkopf; Ken Dutton-Regester; Peter Johansson; Antonia L Pritchard; Nicola Waddell; Victoria K Hill; Jimmy C Lin; Yael Hevroni; Steven A Rosenberg; Javed Khan; Shifra Ben-Dor; Masha Y Niv; Igor Ulitsky; Graham J Mann; Richard A Scolyer; Nicholas K Hayward; Yardena Samuels
Journal:  Nat Genet       Date:  2015-10-26       Impact factor: 38.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.